RheoSCAN engages in the development and marketing of products and services for the diagnosis of vascular disease. The Company delivers clinical  measurement services, medical devices, and pharmaceuticals for vascular  disease. RheoSCAN's mission is to enhance the rate of diagnosis for vascular disease patients through innovative invention and development.

The RheoScan system can measure rheological properties of blood (i.e., RBC deformability, aggregation, critical stress etc) at research and clinical environments. With adopting leading-edge technologies such as laser-optics and microfluidics, the RheoScan system can provide quick and easy measurements with high precision  and repeatability.